Nuvation Bio Inc. Class A Company Profile
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 9:37 AM ET
Nuvation Bio at a glance
Nuvation Bio Inc. Class A (NYSE: NUVB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. Nuvation Bio is led by Dr. David T. Hung M.D. and employs about 305 people. The company's shares have traded publicly since 2020.
At a market capitalization of $1.71 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001811063, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Nuvation Bio do?
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Nuvation Bio Inc. Class A
- Ticker
- NYSE: NUVB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. David T. Hung M.D.
- Employees
- 305
- Headquarters
- 1500 Broadway, New York, NY, United States
- Phone
- 332 208 6102
- Website
- nuvationbio.com
- IPO year
- 2020
- Market cap
- $1.71B
- SEC CIK
- 0001811063
Companies similar to Nuvation Bio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SEPNSepterna Inc. | 36.63 | -0.73% | $1.71B | vs NUVB |
| ZBIOZenas BioPharma Inc. | 26.62 | +1.45% | $1.74B | vs NUVB |
| BRVEBraveheart Bio Inc. | 19.31 | +1.15% | $1.74B | vs NUVB |
| OCULOcular Therapeutix Inc. | 7.53 | +0.27% | $1.65B | vs NUVB |
| ANIPANI Pharmaceuticals Inc. | 71.40 | -0.81% | $1.64B | vs NUVB |
| BHVNBiohaven Ltd. | 11.95 | +0.13% | $1.80B | vs NUVB |
| CMPSCOMPASS Pathways Plc American Depository Shares | 11.60 | +1.13% | $1.61B | vs NUVB |
| ETONEton Pharmaceuticals Inc. | 55.75 | +1.82% | $1.59B | vs NUVB |